Scientist, Inflammation

Join to apply for the Scientist, Inflammation role at Gilead Sciences.

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID‑19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.

Every member of Gilead’s team plays a critical role in the discovery and development of life‑changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.

The Inflammation Biology group at Gilead Sciences is seeking a highly motivated Scientist to join our collaborative and interdisciplinary research team. The successful candidate will support novel target identification and drug development to address clinical unmet need in inflammatory and autoimmune diseases. As a member of cross‑functional teams, the candidate will use state‑of‑the‑art technologies and innovative methodologies to develop new therapeutics focused on restoring immune tolerance, including targeted cytokines and tissue‑resident immune cell function.

The role offers opportunities for career growth in a fast‑paced and resource‑rich environment.

• Support innovative cellular assay development to identify novel approaches to modulate high‑value targets for immunology and inflammation, incorporating primary immune cells as appropriate.
• Independently design, conduct, and analyze in vitro and in vivo experiments to support target validation and therapeutic hypotheses.
• Proactively evaluate new technologies, develop new assays, and generate scientific hypotheses to enhance our understanding of disease pathogenesis.
• Work cross‑functionally with colleagues in inflammation biology, protein therapeutics, structural and medicinal chemistry, and bioinformatic teams.
• Present findings and recommendations to project teams and senior staff, prepare research reports and peer‑reviewed manuscripts, and contribute to the preparation of IND and patent filings.

• 6+ Years with BS or
• 4+ Years with MS or
• 0+ Years with PhD/PharmD

• Ph.D. in immunology, molecular or cell biology, biochemistry, or related field; with 2+ years postdoctoral experience; OR Masters degree with 8‑10 years industry experience.
• Strong background in cellular biology and/or immunology, and/or cell signaling. Experience with methods to modulate gene expression (e.g., CRISPR, lentiviral transduction), and/or knowledge of preclinical models of inflammation and immune function would be preferred. Familiarity with T‑cell biology, particularly regulatory T cells, would be ideal.
• Demonstrated record of research productivity as evidenced by first‑author publications in top‑tier journals.
• Excellent written, verbal, and interpersonal communication skills and strong organizational skills.

• Create inclusion - knowing the business value of diverse teams, modeling inclusion, and embedding the value of diversity in the way they manage their teams.
• Develop talent - understand the skills, experience, aspirations and potential of their employees and coach them on current performance and future potential. They ensure employees receive the feedback and insight needed to grow, develop and realize their purpose.
• Empower teams - connect the team with the organization by aligning goals, purpose, and organizational objectives, and holding them to account. They provide the support needed to remove barriers and connect their team to the broader ecosystem.

The salary range for this position is: $ – $. Gilead considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. This position may also be eligible for a discretionary annual bonus, discretionary stock‑based…